Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
07/2010
07/01/2010US20100168145 Fused imidazole derivatives and use thereof as aldosterone synthase inhibitors
07/01/2010US20100168138 Anti-Viral Compounds
07/01/2010US20100168136 Alkylsulfone derivatives
07/01/2010US20100168123 Akt protein kinase inhibitors
07/01/2010US20100168107 Imidazole compounds for the treatment of neurodegenerative disorders
07/01/2010US20100168100 Quinoline derivatives as p13 kinase inhibitors
07/01/2010US20100168095 Multi-cyclic cinnamide derivatives
07/01/2010US20100168093 Substituted 3-amino-4 -hydroxy pyrrolidines compounds, their preparation and use as medicaments
07/01/2010US20100168088 Pyrrolidine derivatives as nk-3 receptor antagonists
07/01/2010US20100168082 Heterobicyclic Carboxamides as inhibitors for kinases
07/01/2010US20100168065 Quinolinone derivatives as parp and tank inhibitors
07/01/2010US20100167929 Pyrido-pyrazine derivatives useful as herbicidal compounds
07/01/2010US20100163813 Long wavelength shifted benzotriazole uv-absorbers and their use
07/01/2010CA2748397A1 1, 2, 4 -oxadiazole derivatives and their therapeutic use
07/01/2010CA2748294A1 Piperidine derivatives useful as orexin antagonists
07/01/2010CA2748251A1 Novel bicyclic heterocyclic compound
07/01/2010CA2747807A1 Pyrimidine derivatives and methods of use thereof
07/01/2010CA2747795A1 Isoquinoline derivative
07/01/2010CA2740195A1 Anti-viral compounds
07/01/2010CA2740193A1 Anti-viral compounds
06/2010
06/30/2010EP2202234A1 Purification of paliperidone
06/30/2010EP2202233A1 Method for producing pyrazole fused ring derivative
06/30/2010EP2202232A1 1,2,4-oxadiazole derivatives and their therapeutic use
06/30/2010EP2201011A2 Novel compounds having indazole frameworks, methods for preparing the same and pharmaceutical composition comprising the same
06/30/2010EP2201010A1 Modulators of cystic fibrosis transmembrane conductance regulator
06/30/2010EP2200997A1 Synthesis of deuterated catechols and benzoýd¨ý1,3¨dioxoles and derivatives thereof
06/30/2010EP2200987A1 Arylsulfonylaminomethylphosphonic acid derivatives, the preparation thereof and the use thereof as pharmaceutical compositions
06/30/2010EP2200612A1 Inhibitors of janus kinases
06/30/2010EP2200440A1 Antibacterial amide and sulfonamide substituted heterocyclic urea compounds
06/30/2010EP1735270B1 Diamino alcohols and their use as renin inhibitors
06/30/2010EP1618107B1 Condensed n-heterocyclic compounds and their use as crf receptor antagonists
06/30/2010EP1366760B1 Tablets quickly disintegrated in oral cavity
06/30/2010CN101765596A Inhibitors of hypoxia inducible factor (HIF) useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
06/30/2010CN101759697A Preparation method of evodiamine
06/30/2010CN101759645A P38 inhibitors and methods of use thereof
06/29/2010US7745638 Anticancer agents; such as 4-acetylamino-1H-pyrazole-3-carboxylic acid (4-fluoro-phenyl)-amide
06/29/2010US7745625 Phosphate prodrugs; treating HIV infection; 1-(phosphomethyl)-3-(2-(4-benzoylpiperazin-1-yl)-1,2-dioxoethyl)-4,7-dimethoxy-1H-pyrrolo(2,3-c)pyridine for example; improved water solubility, bioavailability for oral administration
06/29/2010US7745451 2,3-Difluoro-benzyl)-[6-(5-methyl-pyridin-2-yl)-5,6,7,8-tetrahydro-pyrido[4,3-d]pyrimidin-4-yl]-amine, useful for the prevention and treatment of pain, inflammation, cognitive disorders, anxiety and depression in humans
06/29/2010US7745434 1-[4-(4-amino-5-oxo-5H-pyrido[2,3-d]pyrimidin-8-yl)phenyl]-3-(5-tert-butylisoxazol-3-yl)urea; treatment of tyrosine kinase-induced diseases and conditions, such as angiogenesis, cancer, tumour formation, growth and propagation, arteriosclerosis, ocular diseases, such as age-induced macular degeneration
06/29/2010US7745428 [4-(4-imidazo[1,2-a]pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-morpholin-4-yl-methanone, used for treating rheumatoid arthritis in mammals
06/29/2010US7745427 (Calcitonin gene related peptide); azepinone ligands; 1-[(2-methoxyethyl)-2-oxo-6-phenylazepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide; analgesic, antiinflammatory agent; migranes, arthritis, neurodegenerative diseases
06/29/2010CA2417942C 2-(4-pyridyl)amino-6-dialkoxyphenyl-pyrido[2,3-d]pyrimidin-7-ones
06/29/2010CA2383858C Substituted phenyl sulfamoyl carboxamides
06/29/2010CA2383751C Intermediates for the production of quinolone carboxylic acid derivatives
06/29/2010CA2345985C Substituted 1,3-diaryl-2-pyrid-2-yl-3-(pyrid-2-ylamino)propanol derivatives,processes for their preparation, pharmaceuticals comprising these compounds and their use
06/29/2010CA2336967C A3 adenosine receptor antagonists
06/24/2010WO2010071837A1 Pyrazine derivatives useful as inhibitors of atr kinase
06/24/2010WO2010071219A1 16-ketoaspergillimide and pest exterminating agent comprising the same as active ingredient
06/24/2010WO2010070452A1 Fused imidazole carboxamides as trpv3 modulators
06/24/2010WO2010070232A1 Novel rare earth element cryptates including a tetraazatriphenylene unit
06/24/2010WO2010070032A1 Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd
06/24/2010WO2010070022A1 Novel compounds
06/24/2010WO2010070008A1 Substituted bicyclic imidazole derivatives as gamma secretase modulators
06/24/2010WO2010069322A1 Triazolopyridines as phosphodiesterase inhibitors for treatment of dermal diseases
06/24/2010WO2010039851A9 Peripheral opioid receptor antagonists and uses thereof
06/24/2010WO2010033451A3 5-oxazolidin-2-one substituted 1,3,8-triazaspiro [4.5] decan-4-one derivatives useful as orl-1 receptor modulators
06/24/2010WO2010004578A3 Novel and improved processes for the preparation of paliperidone
06/24/2010WO2007095223A3 Pyrrolo(3,2-c) pyridines useful as inhibitors of protein kinases
06/24/2010US20100160369 S1P1 Agonists and Methods of Making And Using
06/24/2010US20100160355 Anti-Viral Compounds
06/24/2010US20100160347 PYRIDO[1,2-a]PYRIMIDIN-4-ONE INHIBITORS OF MAST CELL DEGRANULATION
06/24/2010US20100160346 Neurologically active compounds
06/24/2010US20100160334 Tricyclic anilide spirolactam cgrp receptor antagonists
06/24/2010US20100160333 Novel 3,9-diazabicyclo[3.3.1]nonane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
06/24/2010US20100160328 New compounds useful for dpp-iv enzyme inhibition
06/24/2010US20100160324 Pyrazole derivatives as that modulate the activity of cdk, gsk and aurora kinases
06/24/2010US20100160323 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE
06/24/2010US20100160312 Substituted Pyridone Compounds and Methods of Use
06/24/2010US20100160310 2,4 (4,6) pyrimidine derivatives
06/24/2010US20100160309 Inhibitors of janus kinases and/or 3-phosphoinositide-dependent protein kinase-1
06/24/2010US20100160303 Carbazole carboxamide compounds useful as kinase inhibitors
06/24/2010US20100160255 Spiro-cyclic compound
06/24/2010US20100160163 Fused heterocyclic sulfonylurea compound, herbicide containing the same, and method for controlling weed with the same
06/24/2010US20100158858 Administration of carboline derivatives useful in the treatment of cancer and other diseases
06/24/2010US20100155706 Material for organic photoelectric device including electron transporting unit and hole transporting unit, and organic photoelectric device including the same
06/24/2010CA2747677A1 Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd
06/24/2010CA2747252A1 Pyrazine derivatives useful as inhibitors of atr kinase
06/24/2010CA2747022A1 Triazolopyridines as phosphodiesterase inhibitors for treatment of dermal diseases
06/24/2010CA2746077A1 Fused imidazole carboxamides as trpv3 modulators
06/24/2010CA2744935A1 New compounds
06/24/2010CA2742914A1 Substituted bicyclic imidazole derivatives as gamma secretase modulators
06/23/2010EP2199293A1 One-step process for preparing paliperidone and its oxalate salt
06/23/2010EP2199292A1 7-azaindirubins, 7'-azaindirubins, 7-7'-diazaindirubin and the corresponding 3'-oxime ether derivates: production thereof, their production and use as a medicament
06/23/2010EP2198867A1 Pyrimidine-based compounds useful as GSK-3 inhibitors
06/23/2010EP2197880A1 Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors
06/23/2010EP2197875A1 Diacylglycerol acyltransferase inhibitors
06/23/2010EP2197872A1 Phenylisoquinoline and phenylquinazoline derivatives for the treatment of bone diseases
06/23/2010EP2197844A1 Spiroheterocyclic pyrrolidine dione derivatives useful as pesticides
06/23/2010EP2197552A2 Novel tetrahydrofusedpyridines as histone deacetylase inhibitors
06/23/2010EP2197438A1 Heterocyclic compounds as crth2 receptor antagonists
06/23/2010EP1885724B1 Heterocyclic spiro-compounds as aldosterone synthase inhibitors
06/23/2010EP1735313B1 Substituted diaza-spiro-[4.5]-decane derivatives and their use as neurokinin antagonists
06/23/2010CN1926113B Novel amido-substituted hydroxy-6-phenylphenanthridines and their use as PDE4 inhibitors
06/23/2010CN1688194B 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents
06/23/2010CN101747360A Perylene diimides compound
06/23/2010CN101747339A 1'-thio-aza indirubin compound, application and preparation method thereof
06/23/2010CN101747332A Quinacridone derivatives containing urea bonds and gels thereof
06/23/2010CN101072780B Novel tetracyclic derivative containing heteroatoms useful as sex steroid hormone receptor modulators
06/23/2010CN101039908B Tricyclic lactam derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
06/23/2010CN101007815B Pyrrolehexa-heterocyclic compound and pharmaceutical use thereof